Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what research his Department is undertaking on the efficacy of Ivermectin in the treatment of covid-19.

The Department is closely monitoring the evidence on the case for ivermectin as a treatment for COVID-19. On 23 June, the PRINCIPLE clinical trial platform announced that ivermectin would be investigated to generate robust data on its effectiveness in treating adults aged 18 years old and over who are at higher risk of serious illness from COVID-19. We will closely monitor the data from this trial, as well as emerging evidence from the large number of clinical trials worldwide to expand our evidence-base on the efficacy of ivermectin.